Be Sue-Lynn Moses (Inside Philanthropy) – Well, here we are again. It’s late spring, and the Pershing Square Sohn Cancer Research Alliance recently announced the winners of the 2015 Pershing Square Sohn Prize for Young Investigators in Cancer Research.
On Thursday, May 7th, the Pershing Square Sohn Cancer Research Alliance held its second annual dinner at the Park Avenue Armory, awarding its 2015 Prize in Cancer Research to exceptional innovative scientists in New York City.
Abstract: Pancreatic ductal adenocarcinomas (PDACs) are highly metastatic with poor prognosis, mainly due to delayed detection. We hypothesized that intercellular communication is critical for metastatic progression.
By Amanda Gordon (Bloomberg Business) – Cancer biologist Christine Mayr found common ground Thursday night with Bill Ackman.
By Ransdell Pierson (Reuters) – New therapies that clinical data show can eliminate blood cancers such as leukemia and lymphoma in 40 percent to 90 percent of patients may have to be genetically modified to include a switch that shields healthy cells from attack.
By Caroline Lewis (Crain’s New York Business) – The Pershing Square Sohn Cancer Research Alliance will announce Thursday the second class of early-career cancer researchers to win funding and support through its program.
The Pershing Square Sohn Prize winners are making bold advances in research for leukemia, lymphoma, melanoma, pancreatic, prostate, skin, lung, and breast cancer
By Sabrina Tavernise (The New York Times) – In a letter to colleagues announcing his departure as the director of the National Cancer Institute, Dr. Harold Varmus, 75, quoted Mae West. “I’ve been rich and I’ve been poor,” he wrote, “and rich is better.”
By Bernard Meyerson (Scientific American) From autonomous drones to emergent AI to digital genomes, this year’s list from the World Economic Forum offers its latest glimpse of our fast-approaching technological future
By Gina Kolata (The New York Times) – Chemotherapy and radiation failed to thwart Erika Hurwitz’s rare cancer of white blood cells. So her doctors offered her another option, a drug for melanoma. The result was astonishing.